20 CFR 10.809
§ 10.809 How are payments for medicinal drugs determined?
United States · 20 CFR — Employees' Benefits · Status: effective
Cite this
- Citation
- 20 CFR 10.809, § 10.809 How are payments for medicinal drugs determined?, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/76637
- Permanent ID
ys:prov:76637@1- SHA-256
f8d56ee8eea1b0e5f042d2833f978c744d1c27e98bbcb72702c42d9ea6e6a7ca
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Payment for medicinal drugs prescribed by physicians shall not exceed the amount derived by multiplying the average wholesale price, or as otherwise specified by OWCP, of the medication by the quantity or amount provided, plus a dispensing fee. OWCP may, in its discretion, contract for or require the use of specific providers for certain medications.
(a) All prescription medications identified by National Drug Code (NDC) will be assigned an average wholesale price representing the product's nationally recognized wholesale price as determined by surveys of manufacturers and wholesalers, or by other method designated by OWCP. The Director will establish the dispensing fee, which will not be affected by the location or type of provider dispensing the medication.
(b) The NDCs, the average wholesale prices, and the dispensing fee shall be reviewed from time to time and updated as necessary.
(c) With respect to prescribed medications, OWCP may require the use of generic equivalents where they are available.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.